The oncogenic transcription factor ETS variant 1 (ETV1) becomes overexpressed in many prostate tumors by chromosomal translocations involving the ETV1 gene and androgen-responsive promoters1–4 or by loss of its negative regulator, the ubiquitin ligase COP15,6. Here, ETV1 is linked to prostate neoplasm.